| |
| |
|
| Insider
Information: |
Lloyd George W. |
| Relationship: |
EVP, Investments & CLO |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,000 |
|
|
Indirect Shares
|
993,831 |
|
|
| Direct
Value |
$80,760 |
|
|
|
Indirect Value
|
$26,753,931 |
|
|
| Total
Shares |
996,831 |
|
|
| Total
Value |
$26,834,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Royalty Pharma Plc |
RPRX |
EVP, Investments & CLO |
2023-11-13 |
3,000 |
2023-11-13 |
993,831 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,875,860 |
300,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
400,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
262,760 |
273,960 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-11-16 |
4 |
S |
$42.12 |
$7,029,862 |
I/I |
(165,852) |
714,148 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
150,000 |
220,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-03-02 |
4 |
S |
$46.89 |
$5,867,148 |
I/I |
(125,000) |
300,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-06-07 |
4 |
S |
$45.89 |
$5,676,228 |
I/I |
(122,500) |
260,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-05-23 |
4 |
S |
$40.27 |
$4,026,770 |
I/I |
(100,000) |
530,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-03-28 |
4 |
S |
$37.06 |
$3,706,130 |
I/I |
(100,000) |
225,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-06-02 |
4 |
S |
$33.54 |
$3,159,345 |
I/I |
(93,907) |
128,314 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-05-26 |
4 |
S |
$40.21 |
$3,459,338 |
I/I |
(86,026) |
443,974 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-11-17 |
4 |
S |
$42.39 |
$3,566,832 |
I/I |
(84,148) |
630,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-06-06 |
4 |
S |
$33.82 |
$2,674,796 |
I/I |
(79,099) |
30,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-06-08 |
4 |
S |
$46.47 |
$3,253,631 |
I/I |
(70,000) |
250,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-06-10 |
4 |
S |
$46.45 |
$3,254,369 |
I/I |
(70,000) |
240,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-04-14 |
4 |
S |
$42.12 |
$2,941,920 |
I/I |
(69,822) |
200,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-06-02 |
4 |
S |
$42.09 |
$2,632,513 |
I/I |
(62,500) |
1,050,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-06-04 |
4 |
S |
$44.69 |
$2,686,938 |
I/I |
(60,000) |
280,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-03-22 |
4 |
S |
$46.32 |
$2,535,226 |
I/I |
(54,729) |
256,258 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2022-11-10 |
4 |
AS |
$43.85 |
$2,192,613 |
I/I |
(50,000) |
355,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-07-08 |
4 |
S |
$42.05 |
$2,062,789 |
I/I |
(49,059) |
806,530 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2021-07-06 |
4 |
S |
$42.41 |
$1,549,145 |
I/I |
(36,530) |
849,697 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-07-25 |
4 |
S |
$42.90 |
$1,316,708 |
I/I |
(30,671) |
228,886 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & GC |
• – – |
2022-07-27 |
4 |
S |
$43.76 |
$1,098,445 |
I/I |
(25,100) |
226,014 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP, Investments & CLO |
• – – |
2023-02-23 |
4 |
S |
$37.27 |
$931,658 |
I/I |
(25,000) |
325,000 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
